Sort
82,697 grants matching “vaccine development”
THE CANCER EPITOPE DATABASE AND ANALYSIS RESOURCE
$839,859Alessandro Sette · La Jolla Institute For Immunology · U24 · FY2022 · CA
THE CANCER EPITOPE DATABASE AND ANALYSIS RESOURCE
$839,852Alessandro Sette · La Jolla Institute For Immunology · U24 · FY2021 · CA
THE CANCER EPITOPE DATABASE AND ANALYSIS RESOURCE
$839,850Alessandro Sette · La Jolla Institute For Immunology · U24 · FY2023 · CA
Adjuvants for Skin Immunization: Discovery and Mechanisms
$839,834Ioanna Skountzou · Emory University · R01 · FY2017 · AI
TUBERCULOSIS RESEARCH MATERIALS AND VACINE TESTING
$839,767Colorado State University-Fort Collins · N01 · FY2000 · AI
Role of local antibodies in control of chronic genital herpes
$839,751Anton M Sholukh · Fred Hutchinson Cancer Center · R01 · FY2025 · AI
Biomarkers of Chlamydial Susceptibility and Disease
$839,721Catherine M O'Connell · Univ Of North Carolina Chapel Hill · U19 · FY2023 · AI
Escape of maternal plasma broadly neutralizing antibody as a mechanism of mother to child HIV transmission
$839,636Sallie R. Permar · Weill Medical Coll Of Cornell Univ · R01 · FY2022 · AI
Identification of Novel Mucosal Immune Mechanisms Involved in Protection from HIV-1
$839,551Jennifer M Lund · Fred Hutchinson Cancer Research Center · R01 · FY2020 · AI
Glycan modification, CD4 independence, and Env immunogenicity
$839,486Shiu-Lok Hu · University Of Washington · R01 · FY2010 · AI
Antibody mediated protective immunity against cholera
$839,456Jason B Harris · Massachusetts General Hospital · R01 · FY2018 · AI
Lifespan/Tufts/brown Center for AIDS Research (CFAR)
$839,426Susan Cu-Uvin · Miriam Hospital · P30 · FY2017 · AI
Cytotoxic T Cell Mediated Immunity to Chlamydia
$839,392Michael N Starnbach · Harvard Medical School · R01 · FY2021 · AI
Lysine Acetylation in N. gonorrhoeae Quorum Sensing and Biofilm Formation
$839,372John R Kirby · Medical College Of Wisconsin · R01 · FY2017 · AI
Cytotoxic T Cell Mediated Immunity to Chlamydia
$839,359Michael N Starnbach · Harvard Medical School · R01 · FY2022 · AI
Determinants of HIV-1 innate immune sensing and its role in shaping the lymphoid environment.
$839,256Sunnie Yoh · Scripps Research Institute, The · R01 · FY2024 · AI
Conjugate vaccine impact on pneumococcal carriage, disease, and population geneti
$839,234Jonathan A Finkelstein · Harvard Pilgrim Health Care, Inc. · R01 · FY2010 · AI
Structure-based design of coronavirus subunit vaccines
$839,218Lanying Du · New York Blood Center · R01 · FY2020 · AI
Nucleoside modified mRNA based HIV vaccine
$839,218Drew Weissman · University Of Pennsylvania · R01 · FY2018 · AI
Inducing durable, protective immune memory against malaria
$839,196Stefan H.i. Kappe · Seattle Children'S Hospital · U01 · FY2019 · AI
DEFINING THE INFANT IMMUNE RESPONSE TO HIV
$839,137Julie M Overbaugh · Fred Hutchinson Cancer Research Center · R01 · FY2019 · AI
DEFINING THE INFANT IMMUNE RESPONSE TO HIV
$839,137Julie M Overbaugh · Fred Hutchinson Cancer Research Center · R01 · FY2020 · AI
DEFINING THE INFANT IMMUNE RESPONSE TO HIV
$839,137Julie M Overbaugh · Fred Hutchinson Cancer Research Center · R01 · FY2017 · AI
DEFINING THE INFANT IMMUNE RESPONSE TO HIV
$839,137Julie M Overbaugh · Fred Hutchinson Cancer Research Center · R01 · FY2018 · AI
Personalized neuroblastoma vaccines
$839,128John M Maris · Children'S Hosp Of Philadelphia · U01 · FY2023 · CA